Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2026 07:46 ET | Source: Research and Markets

Antimicrobial Resistance Diagnostic Research Report 2026: Markets, Strategies, Trends and Forecasts 2025-2029 by Pathogen and Technology with Executive Guides and Customization

Dublin, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization" report has been...
January 29, 2026 09:50 ET | Source: Research and Markets

Carbapenem-resistant Enterobacteriaceae Infection Market - A Global and Regional Analysis: Focus Country and Regional Analysis, 2025-2035

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Carbapenem-resistant Enterobacteriaceae Infection Market - A Global and Regional Analysis: Focus Country and Regional Analysis, 2025-2035" has been...
January 29, 2026 08:12 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals Highlights Efficacy of Novel Antibiotic, FPI-2119, against Antimicrobial-resistant Gram-negative Bacteria at the 2026 IMARI Conference

EDMONTON, Alberta , Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, is presenting four posters at the...
January 13, 2026 08:00 ET | Source: Fedora Pharmaceuticals, Inc.

Fedora Pharmaceuticals has Re-emerged to Unveil Novel Class of Antibiotics at 2026 Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)

Edmonton, Alberta, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the...
November 20, 2025 06:00 ET | Source: bioMérieux

4th Edition of bioMérieux Canada Symposium: Over 300 Canadian Health Experts Unite in Toronto to Tackle the Growing Threat of Antimicrobial Resistance

“Antimicrobial resistance is advancing silently, but its consequences are all too real"
November 18, 2025 11:04 ET | Source: Research and Markets

India $184.81 Mn Clindamycin HCL Market Trends, Competitive Landscape, Forecasts and Opportunities, 2031F

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "India Clindamycin HCL Market, By Region, Competition, Forecast and Opportunities, 2021-2031F" report has been added to ResearchAndMarkets.com's...
November 11, 2025 10:21 ET | Source: Research and Markets

India Gentamycin Market Research Report 2025 | Now Available

Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "India Gentamycin Market, By Region, Competition, Forecast and Opportunities, 2021-2031F" report has been added to ResearchAndMarkets.com's...
October 15, 2025 04:00 ET | Source: AKAMPION

Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund

-- Existing and new investors joining forces to support the accelerated development of Omnix´s novel, first-in-class antimicrobials pipeline -- Funding underlines urgent global need for novel,...
August 22, 2025 07:02 ET | Source: Research and Markets

1-Day Virtual Training Course on Antimicrobial Resistance (AMR) and 'One Health' (September 17th, 2025) - Learn About Current and Emerging Regulations Related to AMR at National and International Levels

Dublin, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Training Course" training has been added...
August 22, 2025 06:58 ET | Source: Research and Markets

Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions - 1-Day Online Training Course with 6 CPD Hours (December 10, 2025)

Dublin, Aug. 22, 2025 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance (AMR) and 'One Health': Current Challenges, Regulatory Frontiers and Future Solutions Training Course" training has been added...